Filing Details
- Accession Number:
- 0000950170-24-024300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-01 21:38:23
- Reporting Period:
- 2024-02-29
- Accepted Time:
- 2024-03-01 21:38:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818794 | Dyne Therapeutics Inc. | DYN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1528826 | T Joshua Brumm | 1560 Trapelo Road Waltham MA 02451 | Ceo & President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-29 | 5,520 | $5.54 | 568,991 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-29 | 5,520 | $27.50 | 563,471 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 94,480 | $5.54 | 657,951 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-01 | 18,976 | $28.25 | 638,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-01 | 74,090 | $29.23 | 564,885 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-01 | 1,414 | $29.70 | 563,471 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2024-02-29 | 5,520 | $0.00 | 5,520 | $5.54 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-03-01 | 57,843 | $0.00 | 57,843 | $5.54 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-03-01 | 36,637 | $0.00 | 36,637 | $5.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 102,343 | 2030-07-30 | No | 4 | M | Direct | |
| 44,500 | 2030-07-30 | No | 4 | M | Direct | |
| 342,681 | 2030-07-30 | No | 4 | M | Direct |
Footnotes
- Includes 530,300 unvested RSUs.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $27.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $28.48, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.56 to $29.56, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $29.58 to $29.88, inclusive.
- The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024.
Billionaire Hedge Funds
